Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain

The present research work involves the formulation and development of rivastigmine and coumarin-6 loaded biodegradable Polylactide-co-glycolic acid nanoparticles attached with single and double nasal mucosa/brain targeting ligands. The developed nanocarrier systems were formulated by a solvent evapo...

Full description

Bibliographic Details
Main Author: Gauri, Bhawna
Format: Thesis
Published: Curtin University 2017
Online Access:http://hdl.handle.net/20.500.11937/59107
_version_ 1848760400044097536
author Gauri, Bhawna
author_facet Gauri, Bhawna
author_sort Gauri, Bhawna
building Curtin Institutional Repository
collection Online Access
description The present research work involves the formulation and development of rivastigmine and coumarin-6 loaded biodegradable Polylactide-co-glycolic acid nanoparticles attached with single and double nasal mucosa/brain targeting ligands. The developed nanocarrier systems were formulated by a solvent evaporation method and have a particle size of 189-242 nm and drug loading of 3.4%. These systems showed sustained drug release and brain targeting ability. When tested on rats via intranasal administration, 2.2 and 3.3 folds increase in brain targeting with single and dual ligands nanoparticles respectively in comparison to the drug solution. Our study supports the use of sustained release nanoparticles with dual ligands, in conjunction with intranasal administration to achieve better brain targeting efficiency.
first_indexed 2025-11-14T10:15:10Z
format Thesis
id curtin-20.500.11937-59107
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:15:10Z
publishDate 2017
publisher Curtin University
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-591072022-10-28T03:43:37Z Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain Gauri, Bhawna The present research work involves the formulation and development of rivastigmine and coumarin-6 loaded biodegradable Polylactide-co-glycolic acid nanoparticles attached with single and double nasal mucosa/brain targeting ligands. The developed nanocarrier systems were formulated by a solvent evaporation method and have a particle size of 189-242 nm and drug loading of 3.4%. These systems showed sustained drug release and brain targeting ability. When tested on rats via intranasal administration, 2.2 and 3.3 folds increase in brain targeting with single and dual ligands nanoparticles respectively in comparison to the drug solution. Our study supports the use of sustained release nanoparticles with dual ligands, in conjunction with intranasal administration to achieve better brain targeting efficiency. 2017 Thesis http://hdl.handle.net/20.500.11937/59107 Curtin University fulltext
spellingShingle Gauri, Bhawna
Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain
title Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain
title_full Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain
title_fullStr Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain
title_full_unstemmed Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain
title_short Development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of Rivastigmine into the brain
title_sort development and evaluation of an intranasal nanoparticulate formulation for enhanced transport of rivastigmine into the brain
url http://hdl.handle.net/20.500.11937/59107